Detection of vitamin B12 deficiency in type-2 diabetes patients may lower nerve damage risk
Research, presented at the Society for Endocrinology annual conference, suggests that screening for vitamin B12 deficiency in type-2 diabetes patients, treated with metformin, can reduce their risk of developing nerve damage.Science Daily
Source: Society for Endocrinology - Category: Endocrinology Source Type: news
More News: Conferences | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Metformin | Science | Vitamin B12 | Vitamin B12 Deficiency | Vitamins